GlassScriptPhysician profile
Alberto A Mitrani
NPI 1447217005
$1,788.81
in general payments reported to CMS, 2019-2025
19 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $291 · 2022: $22.18 · 2023: $195 · 2024: $385 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $942.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $323.04 | 2024-2025 | Fetroja |
| Allergan, INC. | $270.21 | 2019-2020 | |
| Amgen INC. | $190.75 | 2019-2023 | Repatha, Otezla |
| Boston Scientific Corporation | $131.29 | 2023 | Watchman Access System |
| Paratek Pharmaceuticals, INC. | $121.13 | 2025 | Nuzyra |
| Ablative Solutions, INC. | $120.95 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $99.71 | 2019-2025 | Airsupra |
| Pfizer INC. | $87.44 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $78.39 | 2024-2025 | |
| Amneal Pharmaceuticals LLC | $70.81 | 2019-2025 | Unithroid |
| Sanofi-Aventis U.S. LLC | $66.64 | 2019 | |
| Amarin Pharma, INC. | $62.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $40.65 | 2019-2024 | Xarelto |
| Lilly USA, LLC | $34.29 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Ibsa Pharma INC. | $22.18 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.70 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.02 | 2024 | Livalo |
| Exact Sciences Corporation | $17.79 | 2025 | The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Mitrani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.